Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HK.25NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
EG.5.1.11NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
HK.9NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
XBB.2.3.15NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
GK.2.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
HK.1.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
HN.4.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
XBB.1.16.17NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
GK.1.10NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
FL.13.4.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
EG.5.1.15NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
JY.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XBB.1.16.24NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
XDD.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
XBB.1.16.9NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
GK.6NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
EG.5.2.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
HW.1.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
HN.7NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
GE.1.6NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
EG.5.1.9NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
XCHNUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-713.74US
JF.3NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
HK.17NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
DV.7.1.7NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
DV.7.1.3NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
JP.1.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XCT.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
HK.15NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
GS.7NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
FY.5.4NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FE.1.1.5NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
HK.20NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
GK.12NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
HK.14NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
XDCNUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FL.15.4NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
JR.1.1.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
JD.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
JG.3.3NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
KE.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
HV.1.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
BA.2.86.5NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
HK.8NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
HK.26.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
XCPNUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
FL.1.8NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
EG.6.1.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
EG.5.1.12NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
JF.1.1.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used